Deep Dive Into Elevance Health Stock: Analyst Perspectives (7 …

Apr 4, 2024 · 3M Ago. 0. 4. 0. 0. 0. Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $565.57, a high estimate of $584.00, …

CouponFollow Extension

$565.57
OFF

Deep Dive Into Elevance Health Stock: Analyst Perspectives (7 …

1 week from now

Apr 4, 2024 · 3M Ago. 0. 4. 0. 0. 0. Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $565.57, a high estimate of $584.00, …

businessinsider.com

$556.29
OFF

Peeling Back The Layers: Exploring Elevance Health Through …

1 week from now

Feb 14, 2024 · In the assessment of 12-month price targets, analysts unveil insights for Elevance Health, presenting an average target of $556.29, a high estimate of $580.00, and a low …

businessinsider.com

$547
OFF

Breaking Down Elevance Health: 15 Analysts Share Their Views

1 week from now

Nov 5, 2024 · Analysts have recently evaluated Elevance Health and provided 12-month price targets. The average target is $547.4, accompanied by a high estimate of $622.00 and a low …

nasdaq.com

$607.47
OFF

What Analysts Are Saying About Elevance Health Stock

1 week from now

Aug 19, 2024 · In the assessment of 12-month price targets, analysts unveil insights for Elevance Health, presenting an average target of $607.47, a high estimate of $649.00, and a low …

nasdaq.com

$600.08
OFF

13 Analysts Have This To Say About Elevance Health

1 week from now

Sep 5, 2024 · Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $600.08, along with a high estimate of $643.00 and a low …

nasdaq.com

3%
OFF

Elevance Health Beats EPS Estimates, Raises 2024 Guidance

1 week from now

Apr 22, 2024 · The new adjusted diluted EPS guidance inched from $37.10 to $37.20 for 2024; this target would be a 12.3% increase year over year. Elevance Health's strategic partnerships …

fool.com

3%
OFF

Why Is Elevance Health (ELV) Up 7.3% Since Last Earnings Report?

1 week from now

Aug 16, 2024 · Elevance Health reported second-quarter 2024 adjusted earnings of $10.12 per share, which outpaced the Zacks Consensus Estimate by 1.3%. The bottom line improved …

yahoo.com

$559.91
OFF

Decoding 11 Analyst Evaluations For Elevance Health - Nasdaq

1 week from now

Oct 21, 2024 · Analysts have set 12-month price targets for Elevance Health, revealing an average target of $559.91, a high estimate of $622.00, and a low estimate of $478.00. …

nasdaq.com

15%
OFF

Elevance Health: Reaffirmed Long-Term Target Is Reassuring

1 week from now

Mar 28, 2023 · The reassuring fact is that management has reaffirmed its long-term EPS growth target of 12-15%, and plans to allocate 50% of its capital deployment towards investment and …

seekingalpha.com

$262
OFF

Steris Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

1 week from now

17 hours ago · 0. 0. Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $262.5, along with a high estimate of $265.00 and a low …

benzinga.com

$322.83
OFF

Alnylam Pharmaceuticals Stock: A Deep Dive Into Analyst …

1 week from now

6 days ago · 0. In the assessment of 12-month price targets, analysts unveil insights for Alnylam Pharmaceuticals, presenting an average target of $322.83, a high estimate of $400.00, and a …

nasdaq.com

FAQs about Deep Dive Into Elevance Health Stock: Analyst Perspectives (7 … Coupon?

How do analysts evaluate Elevance Health (EH) stock?

Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Elevance Health compared to the broader market. Price Targets: Gaining insights, analysts provide estimates for the future value of Elevance Health's stock. ...

How can I view Elevance health's market performance?

To gain a panoramic view of Elevance Health's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table. Stay up to date on Elevance Health analyst ratings. ...

What is the average price target for Elevance health?

This current average represents a 1.13% decrease from the previous average price target of $562.67. A clear picture of Elevance Health's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. ...

Does Elevance health have a strong market position?

Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position. Revenue Challenges: Elevance Health's revenue growth over 3 months faced difficulties. ...

Did Elevance health's adjusted EPs exceed analysts' forecasts?

Elevance Health's adjusted EPS exceeded analysts' forecasts, indicating robust financial health. Revenue grew year over year but slightly missed expectations, spotlighting areas for operational fine-tuning. Management's revised earnings guidance suggests a positive trajectory. ...

Does Elevance health have a good return on equity?

Return on Equity (ROE): Elevance Health's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 2.2%, the company showcases efficient use of equity capital and strong financial health. Return on Assets (ROA): Elevance Health's ROA stands out, surpassing industry averages. ...